Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam combinations with ephedrine, dexamethasone, or dexmedetomidine during laparoscopic cholecystectomy
IRCT20141209020258N151Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in cholecystectomy comparing Midazolam + ephedrine, Midazolam + dexamethasone and Midazolam + dexmedetomidine (3 arms). Primary endpoints: Nausea, Vomiting and 2 more. Started Mar 2021; status: completed.
02
Drugs
midazolamephedrinedexamethasonedexmedetomidine
03
Conditions
cholecystectomy
Beyond the preview
Go deeper on IRCT20141209020258N151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N151.